Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization
Open Access
- 12 September 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 74 (6) , 1074-1082
- https://doi.org/10.1189/jlb.0203067
Abstract
The opiates are well-established immunomodulatory factors, and recent evidence suggests that μ- and δ-opioid receptor ligands alter chemokine-driven chemotactic responses through the process of heterologous desensitization. In the present report, we sought to examine the capacity of μ- and δ-opioids to modulate the function of chemokine receptors CCR5 and CXCR4, the two major human immunodeficiency virus (HIV) coreceptors. We found that the chemotactic responses to the CCR1/5 ligand CCL5/regulated on activation, normal T expressed and secreted, but not the CXCR4 ligand stromal cell-derived factor-1α/CXCL12 were inhibited following opioid pretreatment. Studies were performed with primary monocytes and Chinese hamster ovary cells transfected with CCR5 and the μ-opioid receptor to determine whether cross-desensitization of CCR5 was a result of receptor internalization. Using radiolabeled-binding analysis, flow cytometry, and confocal microscopy, we found that the heterologous desensitization of CCR5 was not associated with a significant degree of receptor internalization. Despite this, we found that the cross-desensitization of CCR5 by opioids was associated with a decrease in susceptibility to R5 but not X4 strains of HIV-1. Our findings are consistent with the notion that impairment of the normal signaling activity of CCR5 inhibits HIV-1 coreceptor function. These results have significant implications for our understanding of the effect of opioids on the regulation of leukocyte trafficking in inflammatory disease states and the process of coreceptor-dependent HIV-1 infection. The interference with HIV-1 uptake by heterologous desensitization of CCR5 suggests that HIV-1 interaction with this receptor is not passive but involves a signal transduction process.Keywords
Funding Information
- NIH (DA-06650, DA-11130, DA-14230, DA-04745, P30 DA-13429, DA-11263, T32 DA-07237, F31 DA-05894, T32 AI-07101)
This publication has 51 references indexed in Scilit:
- Human Immunodeficiency Virus-1 Infection Requires Pertussis Toxin Sensitive G-Protein-Coupled Signalling and Mediates cAMP DownregulationBiochemical and Biophysical Research Communications, 1999
- Opiates Transdeactivate Chemokine Receptors: δ and μ Opiate Receptor–mediated Heterologous DesensitizationThe Journal of Experimental Medicine, 1998
- Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migrationEuropean Journal of Immunology, 1997
- Complementary DNA Cloning of a μ-Opioid Receptor from Rat Pertitoneal MacrophagesBiochemical and Biophysical Research Communications, 1995
- δ-Opioid Receptor Gene Expression in LymphocytesBiochemical and Biophysical Research Communications, 1994
- Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophagesLife Sciences, 1993
- Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell culturesInternational Journal of Immunopharmacology, 1993
- κ-Opioid binding sites on a murine lymphoma cell lineEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells.Journal of Clinical Investigation, 1987
- A practical computer-based approach to the analysis of radioligand binding experimentsComputer Programs in Biomedicine, 1983